Unknown OBSERVATIONAL NCT03430414

Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response

Transcriptome Analysis of Stored Biopsy Samples in Clinically Precisely Phenotyped Therapy-responders Versus Non-responders Diagnosed With Antibody Mediated Rejection

Sponsor: Thomas Mueller

Conditions Antibody-mediated Rejection

Interventions Transcriptome Analysis

Updated 9 times since 2018 Last updated: Feb 5, 2018 Started: Feb 15, 2018 Primary completion: Mar 1, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Antibody-mediated Rejection, this trial is ongoing. The trial is conducted by Thomas Mueller and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 4 earlier versions

Mar 2020 — Nov 2020 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
May 2018 — Mar 2020 [monthly]

Not Yet Recruiting
Apr 2018 — May 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Mar 2018 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Thomas Mueller

Data source: University of Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.